ClinVar Miner

Submissions for variant NM_005188.4(CBL):c.-5A>G

gnomAD frequency: 0.00013  dbSNP: rs552214111
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001193460 SCV001362308 benign not specified 2019-12-24 criteria provided, single submitter clinical testing Variant summary: CBL c.-5A>G is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 0.00011 in 166128 control chromosomes. The observed variant frequency is approximately 46 fold of the estimated maximal expected allele frequency for a pathogenic variant in CBL causing Noonan Syndrome and Related Conditions phenotype (2.5e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.-5A>G in individuals affected with Noonan Syndrome and Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign.
GeneDx RCV001619898 SCV001845729 likely benign not provided 2019-07-19 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV001193460 SCV002070073 uncertain significance not specified 2020-01-28 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001619898 SCV004564307 likely benign not provided 2023-09-21 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003938551 SCV004748951 likely benign CBL-related condition 2019-06-11 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.